Cargando…
Promyelocytic Leukemia Antigen Expression: a Histological Marker for Primary Biliary Cholangitis Diagnosis?
BACKGROUND AND OBJECTIVES: Distinguishing primary biliary cholangitis (PBC) from other cholestatic diseases at the histological level could be assisted by new methods, such as immunohistochemical staining of specific antigens. METHODS: We evaluated whether the detection of promyelocytic leukemia pro...
Autores principales: | Papamichalis, Panagiotis A., Zachou, Kalliopi, Papamichali, Roidoula A., Ioannou, Maria, Gatselis, Nikolaos K., Dalekos, George N., Koukoulis, George K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016348/ https://www.ncbi.nlm.nih.gov/pubmed/33850801 http://dx.doi.org/10.2478/jtim-2021-0008 |
Ejemplares similares
-
Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren’s Syndrome and Primary Biliary Cholangitis
por: Arvaniti, Pinelopi, et al.
Publicado: (2019) -
Early Primary Biliary Cirrhosis: A New Association with Erythema Nodosum of Unknown Origin
por: Gatselis, Nikolaos K., et al.
Publicado: (2010) -
First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients
por: Dalekos, George N., et al.
Publicado: (2022) -
Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis
por: Dalekos, George N., et al.
Publicado: (2022) -
FibroMeter scores are predictive noninvasive markers of advanced and significant liver fibrosis in patients with chronic viral hepatitis or metabolic dysfunction-associated steatotic liver disease
por: Arvaniti, Pinelopi, et al.
Publicado: (2023)